Bioventus selling $415 million in notes to fund CartiHeal deal | Secondary Sources | Westlaw

Bioventus selling $415 million in notes to fund CartiHeal deal | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, Bioventus selling $415 million in notes to fund CartiHeal deal, Secondary Sources
Skip Page Header

Bioventus selling $415 million in notes to fund CartiHeal deal

2022 CPMTDBREF 0031By Cory HesterWestlaw Capital Markets Daily Briefing (Approx. 2 pages)

Bioventus selling $415 million in notes to fund CartiHeal deal

2022 CPMTDBREF 0031By Cory HesterWestlaw Capital Markets Daily Briefing (Approx. 2 pages)

Bioventus selling $415 million in notes to fund CartiHeal deal

(April 28, 2022) - Medical device company Bioventus Inc. has launched a private note offering worth $415 million to fund its pending purchase of the remaining interest in orthopedic device maker CartiHeal Ltd.
Bioventus Inc. Form 8-K, ...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.